Finance and efficiency

Value-based pricing 'will not improve' cancer drug access

By 2012-05-03T00:00:00

DNA

Source: Creative images

Government proposals to introduce a value-based pricing system for new drugs will not significantly improve patient access to treatments, experts have warned.

You need to be a subscriber to read more

HSJ

Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All HSJ news by sector, topic & region
  • Breaking News announcements
  • App for mobile and offline reading
  • Comment and Daily Insights newsletters
  • Regional roundup newsletters
  • 10 expert briefings every fortnight (Premium only)
  • Unrestricted access to ‘Ask HSJ’ - AI assistant - AI assistant (Premium only)

Subscribe

to HSJ

Already a subscriber? Sign into your account here